Cetoacidosis diabética y estado hiperglucémico hiperosmolar en COVID-19. Reporte de casos

Goethe Salomon Sacoto Flores, Goethe Salomon Sacoto Flores, Galo Dario Sanchez Coraizaca, Luis Andres Cajilema Acero, Maria Ximena Sanango Jara

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Introduction: Introduction: Diabetes Mellitus (DM) is an independent risk factor to predict severity in COVID-19 infection.Clinical cases: we present four cases of hyperglycemic seizures type hyperosmolar nonketotic state (EHNC) and diabetic ketoacidosis (DKA) associated with COVID-19, three with a history of DM and one with a new diagnosis of DM. The outcome was fatal for the CAD cases and the EHNC case was discharged in stable condition.Conclusion: it is essential to understand the presentation characteristics of acute complications of diabetes in patients with COVID-19 and to suspect this type of metabolic alterations in SARS-CoV-2 infection, important aspects for a timely diagnosis and treatment, greatly improving the prognosis of patients
Idioma originalEspañol
PublicaciónRevista de la Facultad de Ciencias Médicas de la Universidad de Cuenca
EstadoPublicada - 1 ene. 2021

Palabras clave

  • COVID-19; Diabetes mellitus; Cetoacidosis diabética

Citar esto